Shilpa Medicare informs about company updates

29 Jul 2019 Evaluate

Shilpa Medicare has informed that the Company has completed USFDA audit at its API site, Raichur between 22nd July 2019 and 26th July 2019. The Company has received Form 483 with 5 observations, with no repeat observations and any data integrity observations. The observations are mostly procedural in nature.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

320.35 0.50 (0.16%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×